Stanford Professor Barry M. Trost Visits WuXi PharmaTech and Gives Two Seminars

May 21, 2008, 01:00 ET from WuXi PharmaTech

    SHANGHAI, China, May 21 /Xinhua-PRNewswire/ -- WuXi PharmaTech (NYSE:  
 WX), a leading pharmaceutical, biotechnology and medical device research
 and development outsourcing company with operations in China and the United
 States, is proud to announce that the distinguished Stanford University
 Professor Barry M. Trost ( ) has
 visited WuXi PharmaTech and given two seminars on May 19 and 20.
     (Logo: )
     Dr. Barry M. Trost, Tamaki Professor of Humanities and Sciences in the
 chemistry department at Stanford University, is a world renowned organic
 chemist and a fellow of the U.S. National Academy of Sciences. Professor
 Barry M. Trost's professional interests include asymmetric allylic
 alkylation and efficient enantioselective synthesis. He has made great
 contributions to the modern synthetic organic chemistry and green
 chemistry. Many widely used chemistry reactions, such as the Trost
 asymmetric allylic alkylation, Tsuji-Trost reaction and the Trost ligand,
 are named after him.
     Professor Trost studied at the University of Pennsylvania and received
 his Ph.D. from the Massachusetts Institute of Technology in 1965. He was a
 professor at the University of Wisconsin-Madison from 1965 until his
 appointment to Stanford University in 1987. Professor Trost has more than
 820 scientific publications, over 320 lectures at various national and
 international meetings, and over 40 worldwide awards and honors.
     As another luminary speaker of WuXi PharmaTech Science Seminar Series,
 Professor Trost gave the WuXi scientists two lectures titled "New Synthetic
 Strategies to Bioactive Products" and "On Inventing Reactions for Atom
 Economy." Professor Trost captivated the audience from beginning to end
 during the lectures and answered questions from the packed crowd.
     "This is my first time to give a lecture to a pharmaceutical service
 company in China. I am very impressed by WuXi's Science Seminar Series
 program as well as the research capability and scientific acumen of WuXi's
 young scientists. Talents are absolutely the key to success for any
 business, especially for WuXi which provides high quality research and
 development services to global life science companies," commented Professor
 Barry M. Trost.
     "We are very privileged to have Dr. Trost share his brilliant expertise
 with our young scientists," commented Dr. Ge Li, Chairman and Chief
 Executive Officer of WuXi PharmaTech. "As we broaden our R&D service scope
 our success very much depends on the quality of our scientists. Investing
 in people is and will continue to be one of our top strategies."
     About WuXi PharmaTech
     WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical
 device R&D outsourcing company, with operations in China and the United
 States. As a research-driven and customer-focused company, WuXi PharmaTech
 provides pharmaceutical, biotechnology and medical device companies a broad
 and integrated portfolio of laboratory and manufacturing services
 throughout the drug and medical device R&D process. WuXi PharmaTech's
 services are designed to assist its global partners in shortening the cycle
 and lowering the cost of drug and medical device R&D. For more information,
 please visit: .
For more information, please contact: Sherry Shao Tel: +86-21-5046-4002 Email:

SOURCE WuXi PharmaTech